Clinical Trial Update: The Efficacy and Safety of ZR2 Versus R-CHOP-like Regimen for Elderly Patients With Newly Diagnosed Diffuse Large B Cell Lymphoma. [Phase 2]

View source ↗

Summary

Phase 2 trial comparing ZR2 to a R-CHOP-like regimen in elderly patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• R-CHOP-like regimen
• ZR2

Snippet

Sponsor: First Affiliated Hospital of Wenzhou Medical University | Conditions: Diffuse Large B Cell Lymphoma | Phase 2 | Status: UNKNOWN